Publizoom

AOK Sachsen - Anhalt

Magdeburg

Open calls for tenders
27
Awarded contracts
21
Published notices
50

Open calls for tenders

Call for tenders Services German

Video consultation

AOK Sachsen - Anhalt · Magdeburg, Germany

Tenders due in 29 days Published on 22 October 2026

Its contracts coming to an end

Planned endContractCurrent holderAmount
22 July 2028
re-tender around January 2028		 Projekt sAVe - eMMa RpDoc Solutions GmbH
1 bid received		 –
31 August 2028
re-tender around March 2028		 Arzneimittelrabattvertrag nach § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V zu dem Arzneimittel Faktor VIII SDH (B02BD02) zur Behandlung der Hämophilie Intersero GmbH
1 bid received		 €1
31 August 2028
re-tender around March 2028		 Arzneimittelrabattvertrag nach § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V zu den Arzneimitteln Haemoctin SDH (B02BD02) und Haemonine (B02BD04) zur Behandlung der Hämophilie Biotest GmbH & Co. KGaA
1 bid received		 €1
31 August 2028
re-tender around March 2028		 Arzneimittelrabattvertrag nach § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V zu dem Arzneimittel Fanhdi (B02BD06) zur Behandlung der Hämophilie Grifols Deutschland GmbH
1 bid received		 €1
31 August 2028
re-tender around March 2028		 Arzneimittelrabattvertrag zu den Arzneimitteln Advate (B02BD02),Recombinate (B02BD02),Rixubis (B02BD04),Feiba (B02BD03),Immunate (B02BD06),Immuseven (B02BD05),Adynovi (B02BD02),Veyvondi (B02BD10) Takeda GmbH
1 bid received		 €1
31 August 2028
re-tender around March 2028		 Arzneimittelrabattvertrag nach § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V zu den Arzneimitteln Haemate P (B02BD06) und Voncento (B02BD06) zur Behandlung der Hämophilie CSL Behring GmbH
1 bid received		 €1
31 August 2028
re-tender around March 2028		 Arzneimittelrabattvertrag nach § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V zu den Arzneimitteln Benefix (B02BD04) und ReFacto AF (B02BD02) zur Behandlung der Hämophilie Pfizer Pharma GmbH
1 bid received		 €1
31 August 2028
re-tender around March 2028		 Arzneimittelrabattvertrag nach § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V zu den Arzneimitteln Alprolix (B02BD04), Elocta (B02BD02) und Altuvoct (B02BD02) zur Behandlung der Hämophilie Swedish Orphan Biovitrum GmbH
1 bid received		 €1
31 August 2028
re-tender around March 2028		 Arzneimittelrabattvertrag nach § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V zu den Arzneimitteln Nuwiq (B02BD02), Octanate (B02BD02), Octanine F (B02BD04) und Wilate (B02BD06) bei Hämophilie Octapharma GmbH
1 bid received		 €1
31 August 2028
re-tender around March 2028		 Gewährung von Rabatten bei der Abgabe von Fertigarzneimitteln mit der Wirkstoffkombination Valsartan und Sacubitril (ATC-Code: C09DX04) Novartis Pharma GmbH
1 bid received		 €1
31 August 2028
re-tender around March 2028		 Arzneimittelrabattvertrag nach § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V zu den Arzneimitteln Kovaltry (B02BD02) und Jivi (B02BD02) zur Behandlung der Hämophilie Bayer Vital GmbH
1 bid received		 €1
31 August 2028
re-tender around March 2028		 Arzneimittelrabattvertrag nach § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V zu den Arzneimitteln Esperoct (B02BD02), NovoEight (B02BD02) und Alhemo (B02BX10) zur Behandlung der Hämophilie Novo Nordisk Pharma GmbH
1 bid received		 €1
22 July 2029
re-tender around January 2029		 Projekt sAVe - RRA RpDoc Solutions GmbH
1 bid received		 –

Competition observed: 1,0 bids on average per contract (across 13 awarded contracts).

Who wins its contracts

Awarded contracts

Award notice Supplies German

Projekt sAVe - eMMa

AOK Sachsen - Anhalt · Magdeburg, Germany

Published on 11 August 2026

Award notice Supplies German

Projekt sAVe - RRA

AOK Sachsen - Anhalt · Magdeburg, Germany

Published on 11 August 2026

Source: TED (Publications Office of the European Union), notices above the EU thresholds.